Your browser doesn't support javascript.
loading
The Effect of Gua Sha Therapy on Pain in Parkinson's Disease: a Randomized Controlled Trial.
Xu, Yu Chen; Wang, Qiu Qin; Chen, Meng Yuan; Gao, Yu Jie; Wang, Jia Yi; Ge, Hao Tian; Weng, Heng; Chen, Ju Ping; Xu, Gui Hua.
Afiliação
  • Xu YC; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Wang QQ; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Chen MY; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Gao YJ; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Wang JY; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Ge HT; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Weng H; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Chen JP; Department of Neurology, Changshu Hospital of Traditional Chinese Medicine, Suzhou, 215500, People's Republic of China.
  • Xu GH; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
Int J Gen Med ; 17: 2791-2800, 2024.
Article em En | MEDLINE | ID: mdl-38962174
ABSTRACT

Purpose:

Pain is a common yet undertreated symptom of Parkinson's disease (PD). This study investigated the effect of Gua Sha therapy on pain in patients with PD. Patients and

Methods:

A total of 56 PD patients with pain were randomized into either the experimental group (n=28), receiving 12 sessions of Gua Sha therapy, or the control group (n=28) without additional treatment. Participants underwent assessment at baseline, after the twelfth invention, and at the 2-month follow-up timepoints. The primary outcome was KPPS and VAS. Secondary outcomes included UPDRS I-III, PDSS-2, HADS, PDQ-39, and blood biomarkers (5-HT, IL-8, IL-10).

Results:

The experimental group reported a significant improvement in pain severity, motor functions, affective disorder, and sleep quality (P < 0.05). Furthermore, increasing trends in both 5-HT and IL-10, as well as decreasing trends in IL-8 were observed. No serious adverse events occurred.

Conclusion:

The preliminary findings suggest that Gua Sha therapy may be effective and safe for alleviating pain and improving other disease-related symptoms in PD patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article